Literature DB >> 25213184

Integrated analysis of CRLF2 signaling in acute lymphoblastic leukemia identifies Polo-like kinase 1 as a potential therapeutic target.

Tai-Chung Huang1, Jevon Cutler, Shubhada Bharne, Jun Zhong, David Weinstock, Jeffrey Tyner, Ivana Gojo, Curt Civin, Akhilesh Pandey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25213184      PMCID： PMC4420723          DOI： 10.3109/10428194.2014.963076

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

1.  Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms.

Authors:  Anna A Birukova; Ksenya Smurova; Konstantin G Birukov; Peter Usatyuk; Feng Liu; Kozo Kaibuchi; Anila Ricks-Cord; Viswanathan Natarajan; Irina Alieva; Joe G N Garcia; Alexander D Verin
Journal:  J Cell Physiol       Date:  2004-10       Impact factor: 6.384

Review 2.  Polo-like kinases: conservation and divergence in their functions and regulation.

Authors:  Vincent Archambault; David M Glover
Journal:  Nat Rev Mol Cell Biol       Date:  2009-04       Impact factor: 94.444

3.  Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia.

Authors:  E Chapiro; L Russell; E Lainey; S Kaltenbach; C Ragu; V Della-Valle; K Hanssens; E A Macintyre; I Radford-Weiss; E Delabesse; H Cavé; T Mercher; C J Harrison; F Nguyen-Khac; P Dubreuil; O A Bernard
Journal:  Leukemia       Date:  2009-11-12       Impact factor: 11.528

4.  Stroma-supported immunocytometric assay (SIA): a novel method for testing the sensitivity of acute lymphoblastic leukemia cells to cytotoxic drugs.

Authors:  D Campana; A Manabe; W E Evans
Journal:  Leukemia       Date:  1993-03       Impact factor: 11.528

5.  Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

Authors:  Akinori Yoda; Yuka Yoda; Sabina Chiaretti; Michal Bar-Natan; Kartik Mani; Scott J Rodig; Nathan West; Yun Xiao; Jennifer R Brown; Constantine Mitsiades; Martin Sattler; Jeffrey L Kutok; Daniel J DeAngelo; Martha Wadleigh; Alfonso Piciocchi; Paola Dal Cin; James E Bradner; James D Griffin; Kenneth C Anderson; Richard M Stone; Jerome Ritz; Robin Foà; Jon C Aster; David A Frank; David M Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

6.  Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase.

Authors:  Young-Joo Jang; Sheng Ma; Yasuhiko Terada; Raymond L Erikson
Journal:  J Biol Chem       Date:  2002-08-30       Impact factor: 5.157

7.  Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; J Racquel Collins-Underwood; Letha A A Phillips; Michael G Loudin; Wei Liu; Jinghui Zhang; Jing Ma; Elaine Coustan-Smith; Richard C Harvey; Cheryl L Willman; Fady M Mikhail; Julia Meyer; Andrew J Carroll; Richard T Williams; Jinjun Cheng; Nyla A Heerema; Giuseppe Basso; Andrea Pession; Ching-Hon Pui; Susana C Raimondi; Stephen P Hunger; James R Downing; William L Carroll; Karen R Rabin
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

8.  Myosin phosphatase-targeting subunit 1 regulates mitosis by antagonizing polo-like kinase 1.

Authors:  Shigeko Yamashiro; Yoshihiko Yamakita; Go Totsukawa; Hidemasa Goto; Kozo Kaibuchi; Masaaki Ito; David J Hartshorne; Fumio Matsumura
Journal:  Dev Cell       Date:  2008-05       Impact factor: 12.270

9.  Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

Authors:  Lisa J Russell; Melania Capasso; Inga Vater; Takashi Akasaka; Olivier A Bernard; Maria Jose Calasanz; Thiruppavaii Chandrasekaran; Elise Chapiro; Stephan Gesk; Mike Griffiths; David S Guttery; Claudia Haferlach; Lana Harder; Olaf Heidenreich; Julie Irving; Lyndal Kearney; Florence Nguyen-Khac; Lee Machado; Lynne Minto; Aneela Majid; Anthony V Moorman; Heather Morrison; Vikki Rand; Jonathan C Strefford; Claire Schwab; Holger Tönnies; Martin J S Dyer; Reiner Siebert; Christine J Harrison
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

10.  Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial.

Authors:  Hannah M Ensor; Claire Schwab; Lisa J Russell; Sue M Richards; Heather Morrison; Dino Masic; Lisa Jones; Sally E Kinsey; Ajay J Vora; Christopher D Mitchell; Christine J Harrison; Anthony V Moorman
Journal:  Blood       Date:  2010-11-24       Impact factor: 22.113
View more
  2 in total

1.  Antileukemic efficacy of a potent artemisinin combined with sorafenib and venetoclax.

Authors:  Blake S Moses; Samantha McCullough; Jennifer M Fox; Bryan T Mott; Søren M Bentzen; MinJung Kim; Jeffrey W Tyner; Rena G Lapidus; Ashkan Emadi; Michelle A Rudek; Tami J Kingsbury; Curt I Civin
Journal:  Blood Adv       Date:  2021-02-09

2.  CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.

Authors:  Dafné Moreno Lorenzana; María Del Rocío Juárez Velázquez; Adriana Reyes León; Daniel Martínez Anaya; Adrián Hernández Monterde; Consuelo Salas Labadía; María Del Pilar Navarrete Meneses; Marta Zapata Tarrés; Luis Juárez Villegas; Berenice Jarquín Ramírez; Rocío Cárdenas Cardós; Martha Herrera Almanza; Rogelio Paredes Aguilera; Patricia Pérez Vera
Journal:  J Pathol Clin Res       Date:  2021-04-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.